Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) traded down 5.6% on Wednesday . The company traded as low as $36.80 and last traded at $37.02. 583,722 shares were traded during trading, a decline of 48% from the average session volume of 1,126,938 shares. The stock had previously closed at $39.21. Analyst […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s stock price was down 4.2% during mid-day trading on Tuesday . The company traded as low as $12.27 and last traded at $12.31. Approximately 16,561 shares were traded during trading, a decline of 89% from the average daily volume of 148,825 shares. The stock had previously […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) saw an uptick in trading volume on Monday . 51,423 shares traded hands during trading, a decline of 64% from the previous session’s volume of 141,744 shares.The stock last traded at $13.52 and had previously closed at $13.58. Alpine Immune Sciences Trading Down 2.0 % The […]
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) dropped 6.7% during mid-day trading on Friday . The company traded as low as $10.81 and last traded at $10.85. Approximately 39,257 shares traded hands during trading, a decline of 64% from the average daily volume of 109,911 shares. The stock had previously closed at […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) – Equities research analysts at Wedbush issued their Q1 2024 EPS estimates for Alpine Immune Sciences in a research note issued to investors on Friday, March 24th. Wedbush analyst R. Driscoll anticipates that the biotechnology company will post earnings per share of ($0.23) for the quarter. Wedbush […]